Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Classificação em ações #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Preço da ação
$4.00
Última sincronização: 2026-08-20
Valor de mercado
$75.37M
Variação (1 dia)
0.00%
Variação (1 ano)
12.99%
País
US
Negociar RetinalGenix Technologies Inc. (RTGN)

Categoria

Rácio P/B de RetinalGenix Technologies Inc. (RTGN)
Rácio P/B em 2026 TTM: 0
De acordo com os relatórios financeiros mais recentes e o preço das ações da RetinalGenix Technologies Inc., o rácio P/B atual (TTM) é 0. No final de 2026, o rácio P/B era 0.
Histórico do rácio P/B da RetinalGenix Technologies Inc. de 2026 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
- -
DE